ImmunoMet Competitors and Similar CompaniesClear all
ImmunoMet's competitors and similar companies include DNAtriX, Cullinan Oncology and MiNK Therapeutics.
 ImmunoMet ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism. |  Cullinan Oncology Cullinan Oncology is a company that develops cancer treatments and a portfolio of oncology therapeutics. |  MiNK Therapeutics MiNK Therapeutics (formerly AgenTus Biosciences, AgenTus Therapeutics) is a biopharmaceutical company that develops allogeneic iNKT cell therapies to treat cancer and immune-mediated diseases. | ||
Founding Date | Founding Date 2015 | Founding Date 2005 | Founding Date 2016 | Founding Date 2017 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Houston, US HQ | Locations Houston, US HQ San Diego, US | Locations Cambridge, US HQ | Locations New York, US HQ Cambridge, GB |
Employees | Employees 814% increase | Employees 3 | Employees 11131% increase | Employees 34 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 981 m | Valuation ($) 28.9 m |
Financial | ||||
Net income | Net income N/A | Net income N/A | Net income ($219.9m) (FY, 2025) | Net income ($12.5m) (FY, 2025) |
Funding | ||||
Latest funding round | Latest funding round $ 5.2m (over 10 years ago) | Latest funding round $ 15.5m (almost 8 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 54.2m | Total funding raised $ 248.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
DNAtriX
HQ
Houston, US
Employees
3
DNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer.
View companyCullinan Oncology
HQ
Cambridge, US
Employees
111↑ 31% increase
Cullinan Oncology is a company that develops cancer treatments and a portfolio of oncology therapeutics.
View companyMiNK Therapeutics
HQ
New York, US
Employees
34
MiNK Therapeutics (formerly AgenTus Biosciences, AgenTus Therapeutics) is a biopharmaceutical company that develops allogeneic iNKT cell therapies to treat cancer and immune-mediated diseases.
View company